D&O Insurance for US IPOs: Coverage Scope and Placement Strategies for Hong Kong Issuers

The 2024-2025 cycle of US-listed Chinese companies facing securities class actions has reached a frequency not seen since the 2020-2021 wave, with at least 14 new filings against Hong Kong-headquartered or PRC-domiciled issuers on the NYSE and Nasdaq between January and September 2025, according to data from Stanford Law School’s Securities Class Action Clearinghouse. This resurgence, driven by a combination of aggressive plaintiff-side law firms targeting SPAC de-SPAC transactions and the SEC’s continued enforcement focus under its Division of Enforcement’s 2024 priorities, has made Directors & Officers (D&O) insurance a non-discretionary line item for any Hong Kong issuer contemplating a US IPO. The coverage landscape, however, has shifted materially: premiums for US-listed Chinese companies have risen by an estimated 40-60% since 2022, while policy exclusions for regulatory investigations and shareholder derivative suits have narrowed the effective protection. For Hong Kong CFOs, company secretaries, and sponsors navigating a US listing, understanding the precise scope of D&O coverage—particularly the interplay between Side A, Side B, and Side C towers—and the placement strategies that optimise premium-to-coverage ratios is now as critical as the underwriting mechanics of the IPO itself. This article unpacks the coverage architecture, the regulatory risk vectors specific to US-listed Hong Kong issuers, and the broker-led placement strategies that can mitigate the cost of an increasingly hard market.

The Coverage Architecture of D&O for US IPOs

D&O insurance for a US IPO is not a single policy but a layered structure designed to allocate risk across three distinct towers, each responding to different types of claims and defendants. Understanding this architecture is the first step for any Hong Kong issuer, as the placement strategy directly determines the cost and scope of protection.

Side A, Side B, and Side C: The Three Pillars

The standard D&O policy for a US-listed issuer comprises three coverage components. Side A (non-indemnifiable loss) covers directors and officers when the company cannot or will not indemnify them—typically in derivative suits or where corporate indemnification is prohibited by law. Side B (company indemnification) reimburses the company for amounts it has paid to indemnify its directors and officers. Side C (entity coverage) covers the company itself for its own liability, most commonly in securities class actions under Section 10(b) of the Securities Exchange Act of 1934.

For Hong Kong issuers listing via a Cayman Islands or Bermuda holding company—the standard structure for US IPOs—Side A is particularly consequential. The Cayman Islands Companies Act (2023 revision) does not mandate indemnification for directors found liable for fraud or wilful default, meaning Side A coverage must be independently sufficient to protect individual directors. The SEC’s 2024 enforcement action against a Hong Kong-based SPAC sponsor (SEC Administrative Proceeding No. 3-21876, 2024) highlighted this gap: the sponsor’s directors faced personal liability for misleading disclosures in the de-SPAC proxy statement, and the D&O policy’s Side A limit was exhausted within the first six months of defence costs.

Policy Limits and the Tower Structure

A typical D&O programme for a US IPO of a Hong Kong issuer with a market capitalisation between USD 500 million and USD 2 billion will carry a total tower of USD 10 million to USD 25 million in aggregate limits. The tower is usually structured as a primary layer of USD 5 million to USD 10 million, followed by two to three excess layers. The primary layer is critical because it responds first and sets the policy terms—definitions, exclusions, and defence cost provisions—that flow upward.

Data from Aon’s 2025 D&O Market Review indicates that the average premium rate for primary D&O coverage for US-listed Chinese issuers in 2025 was 8.5% of the policy limit, compared to 5.2% for comparable US domestic issuers. This 63% premium differential reflects the heightened perceived risk of securities litigation, regulatory enforcement by both the SEC and the China Securities Regulatory Commission (CSRC), and the complexity of cross-border asset recovery.

Key Exclusions and Their Implications for Hong Kong Issuers

Every D&O policy contains standard exclusions—fraud, personal profit, illegal remuneration—but Hong Kong issuers face three additional exclusions that are often non-negotiable in the current market. First, the regulatory investigation exclusion: policies increasingly exclude coverage for costs incurred in responding to SEC subpoenas, CSRC inquiries, or Hong Kong Securities and Futures Commission (SFC) investigations unless a formal civil or administrative proceeding has been initiated. Given that the SEC’s Division of Enforcement opened 762 investigations in fiscal 2024 (SEC Annual Report, 2024), and that many of these target disclosure issues in US-listed Chinese companies, this exclusion can strip coverage at the most critical stage.

Second, the cross-border sanction exclusion: following the PRC’s 2023 Data Security Law and the 2024 Cybersecurity Standards for Cross-Border Data Transfer, D&O policies now routinely exclude losses arising from any violation of PRC data export restrictions. For a Hong Kong issuer that maintains its primary operations in the PRC while listing in the US, this exclusion creates a coverage gap for any claim that involves data-handling practices.

Third, the VIE structure exclusion: some carriers have introduced specific exclusions for claims arising from the use of Variable Interest Entity (VIE) structures, citing the CSRC’s 2023 rules requiring VIE offshore listings to be filed with the regulator. While not yet universal, this exclusion is becoming more common in excess layers.

Placement Strategies in a Hard Market

The D&O insurance market for US-listed Chinese issuers is classified as “hard” by all major brokers—meaning limited capacity, higher premiums, and stricter underwriting. Hong Kong issuers must adopt a structured placement approach to secure adequate coverage without overpaying.

Timing the Placement: The IPO Window

The optimal time to bind D&O coverage for a US IPO is 60 to 90 days before the expected pricing date. This window allows the broker to present the issuer’s risk profile—including the F-1 registration statement, the corporate governance structure, and the track record of the sponsor or underwriters—to a panel of 8 to 12 carriers. Placing coverage too early (more than 120 days before pricing) risks the policy being voided if material changes occur in the prospectus; placing it too late (less than 30 days before pricing) limits carrier appetite and can force the issuer to accept a higher premium or narrower terms.

A 2024 study by Marsh’s US IPO Practice found that issuers who placed D&O coverage within the 60-90 day window achieved an average premium discount of 12% compared to those who placed within 30 days of pricing, while also securing broader Side A coverage.

Selecting the Lead Carrier

The lead carrier—the insurer underwriting the primary layer—sets the terms for the entire tower. For Hong Kong issuers, the lead carrier should be a carrier with demonstrable claims experience in US securities class actions involving Chinese companies. Three carriers dominate this segment: AIG, Chubb, and Berkshire Hathaway Specialty Insurance. AIG’s 2024 claims database shows it handled 23 securities class actions against US-listed Chinese companies between 2020 and 2024, giving it the deepest actuarial data for pricing.

The lead carrier’s underwriting process will include a detailed review of the issuer’s corporate governance, including the composition of the audit committee (must be majority independent under NYSE or Nasdaq rules), the existence of a whistleblower policy, and the issuer’s compliance with the SFC’s Code of Conduct for Corporate Finance Advisers (Chapter 17, 2023 revision). Issuers that score well on these governance metrics can expect a 10-15% premium reduction on the primary layer.

Layering and the Excess Market

Once the primary layer is bound, the broker builds the excess layers. The excess market for US-listed Chinese issuers is thinner than for domestic US issuers, with only 6 to 8 carriers actively writing excess D&O for this segment, compared to 15 to 20 for domestic US risks. The most common excess carriers are XL Catlin, Axis Capital, and Markel.

A critical structural consideration is the drop-down provision. Excess layers should include a “follow-form” clause, meaning they adopt the terms of the primary policy without adding material exclusions. In the 2024-2025 market, some excess carriers have attempted to insert “regulatory investigation” exclusions at the excess level, even when the primary policy does not contain them. The issuer’s broker must negotiate for a “most-favoured-nation” clause in the excess policies, ensuring that if any excess layer is later replaced with broader terms, all layers are upgraded.

Regulatory Risk Vectors Specific to Hong Kong Issuers

The D&O coverage scope is only as good as the underwriting of the specific regulatory risks the issuer faces. Three vectors are particularly relevant for Hong Kong companies listing in the US.

The SEC’s Focus on China-Based Issuers

The SEC’s Division of Corporation Finance and Division of Enforcement have maintained a dedicated task force for China-based issuers since 2021. In fiscal 2024, the SEC brought 11 enforcement actions against US-listed Chinese companies, including three against Hong Kong-incorporated issuers with PRC operations (SEC Enforcement Statistics, 2024). The most common allegations were misleading revenue recognition under ASC 606 and inadequate disclosure of VIE structures.

For D&O underwriting, the SEC’s focus means that carriers will scrutinise the issuer’s revenue recognition policies and its VIE disclosure in the F-1. Any material weakness in internal controls over financial reporting (ICFR) disclosed in the registration statement will be a red flag, potentially triggering a premium surcharge of 20-30% on the primary layer.

The CSRC’s Filing Requirement

Since 1 March 2023, the CSRC has required all PRC companies—including Hong Kong issuers that derive more than 50% of their revenue from the PRC—to file their offshore listing with the CSRC under the Trial Administrative Measures of Overseas Securities Offerings and Listings. The CSRC’s 2024 annual report noted that it received 1,247 filings in 2024, of which 23 were rejected or required material amendments.

A CSRC rejection or a finding of non-compliance during the listing process can trigger a D&O claim, as shareholders may allege that the issuer misrepresented its regulatory status. D&O policies typically exclude coverage for losses arising from a failure to obtain required regulatory approvals, making it essential that the issuer’s legal counsel confirms CSRC filing compliance before the policy is bound.

The SFC’s Cross-Border Enforcement

The Hong Kong Securities and Futures Commission (SFC) has increasingly coordinated with the SEC under the 2023 Memorandum of Understanding on Enforcement Cooperation. In 2024, the SFC referred two cases involving Hong Kong-listed companies that also had US-listed subsidiaries to the SEC (SFC Annual Report, 2024). For Hong Kong issuers with dual-listed securities—for example, a Hong Kong parent with a US-listed subsidiary—the SFC’s enforcement actions can trigger D&O claims in both jurisdictions.

D&O policies for such issuers should include a cross-jurisdictional defence cost provision, which covers the costs of defending proceedings in both Hong Kong and the US simultaneously. Without this provision, the issuer may face a shortfall if the policy’s defence cost sub-limit is exhausted in one jurisdiction, leaving the other uncovered.

Actionable Takeaways

1. Bind D&O coverage 60-90 days before the US IPO pricing date to secure a 12% average premium discount and broader Side A coverage, based on Marsh’s 2024 US IPO Practice data.
2. Select a lead carrier with a demonstrated claims history in US securities class actions against Chinese issuers, such as AIG or Chubb, and require the broker to negotiate a “most-favoured-nation” clause in all excess layers to prevent coverage erosion.
3. Ensure the policy explicitly excludes the regulatory investigation carve-back for SEC subpoenas and CSRC inquiries, or negotiate a 60-day waiting period before the exclusion applies, to preserve defence cost coverage during the investigation phase.
4. Verify that the issuer’s CSRC filing for the offshore listing is approved before the D&O policy is bound, as any failure to obtain regulatory approval is typically excluded from coverage.
5. Include a cross-jurisdictional defence cost provision in the policy to cover simultaneous proceedings in Hong Kong and the US, particularly for issuers with dual-listed securities or PRC-based operations.